Clinical Trial Update: Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating daily versus twice-daily tamsulosin for symptoms related to ureteral stents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Diseases

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Gundersen Lutheran Medical Foundation | Conditions: Ureteral Diseases | Phase 4 | Status: UNKNOWN